Amprius Technologies, Inc.
For the period ended Dec 31, 2025. Filed Mar 6, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 6, 2026
AMPX$9.17-3.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
FORTHEY EARSE NDEDD ECEMBER 31,2025 AND 2024
| Common Stock · AdditionalPaid-inCapital · Accumulated Other Comprehensive Loss · AccumulatedDeficit · TotalStockholders’Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| (In thousands, except share data) · Shares · Amount | |||||||||||
| Balance as of January 1, 2024 | 88,869,463 | $9 | $189,454 | $— | $(129,663) | $59,800 | |||||
| Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost | 14,701,388 | 2 | 33,261 | — | — | 33,263 | |||||
| Issuance of common stock upon exercise of stock warrants, net of issuance cost | 13,075,664 | 2 | 13,626 | — | — | 13,628 | |||||
| Issuance of common stock upon exchange of stock warrants for shares of common stock | 3,073,200 | — | — | — | — | — | |||||
| Issuance of common stock upon exercise of stock options and vesting of restricted stock units | 2,714,599 | — | 109 | — | — | 109 | |||||
| Cancellation and retirement of common stock | (5,500,000) | (1) | 1 | — | — | — | |||||
| Stock-based compensation | — | — | 7,343 | — | — | 7,343 | |||||
| Net loss | — | — | — | — | (44,671) | (44,671) | |||||
| Balance, December 31, 2024 | 116,934,314 | 12 | 243,794 | — | (174,334) | 69,472 | |||||
| Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost | 10,719,196 | 1 | 63,580 | — | — | 63,581 | |||||
| Issuance of common stock upon exchange of stock warrants for shares of common stock | 200,100 | — | 2,301 | — | — | 2,301 | |||||
| Issuance of common stock upon exercise of stock options and vesting of restricted stock units | 6,682,982 | — | 5,071 | — | — | 5,071 | |||||
| Stock-based compensation | — | — | 7,410 | — | — | 7,410 | |||||
| Net loss | — | — | — | — | (44,024) | (44,024) | |||||
| Other comprehensive income | — | — | — | 4 | — | 4 | |||||
| Balance as of December 31, 2025 | 134,536,592 | $13 | $322,156 | $4 | $(218,358) | $103,815 | |||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.